These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1105 related items for PubMed ID: 17108127

  • 1. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW, Leung PC, Wong AS.
    Cancer Res; 2006 Nov 15; 66(22):10902-10. PubMed ID: 17108127
    [Abstract] [Full Text] [Related]

  • 2. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C.
    Cancer Res; 2009 Aug 15; 69(16):6473-81. PubMed ID: 19638591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    Rosanò L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A.
    Cancer Res; 2001 Nov 15; 61(22):8340-6. PubMed ID: 11719468
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM, Cheng JC, Wang HS, Huang HY, MacCalman CD, Leung PC.
    Cancer Res; 2009 May 15; 69(10):4202-8. PubMed ID: 19366794
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R, Hinz B.
    J Natl Cancer Inst; 2008 Jan 02; 100(1):59-69. PubMed ID: 18159069
    [Abstract] [Full Text] [Related]

  • 9. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells].
    Hu XX, Li L, Li DR, Zhang W, Tang BJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 02; 28(9):662-5. PubMed ID: 17274370
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S, Levy G, Hanoch T, Naor Z, Seger R.
    Cancer Res; 2004 Aug 15; 64(16):5736-44. PubMed ID: 15313914
    [Abstract] [Full Text] [Related]

  • 11. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway.
    Hung SH, Shen KH, Wu CH, Liu CL, Shih YW.
    J Agric Food Chem; 2009 Feb 25; 57(4):1291-8. PubMed ID: 19178296
    [Abstract] [Full Text] [Related]

  • 12. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J, Wang B.
    Gynecol Oncol; 2006 Oct 25; 103(1):199-206. PubMed ID: 16624393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.
    Cancer Res; 2000 Feb 15; 60(4):1121-8. PubMed ID: 10706134
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
    Moretti RM, Montagnani Marelli M, Mai S, Limonta P.
    Int J Oncol; 2008 Aug 15; 33(2):405-13. PubMed ID: 18636163
    [Abstract] [Full Text] [Related]

  • 20. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
    Vayalil PK, Katiyar SK.
    Prostate; 2004 Apr 01; 59(1):33-42. PubMed ID: 14991864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.